Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether half-dose depot triptorelin are as effective as reduced-dose daily buserelin in the controlled ovarian stimulation for intracytoplasmic sperm injection and embryo transfer

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tehran University of Medical Sciences
• Treatments: Buserelin; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• Candidate for ICSI/ET

• 35 years old or younger

• Serum FSH less than 10 IU/l on day three of the previous menstrual cycle

• No more than two previous IVF/ICSI attempts

• No planned percutaneous epididymal sperm aspiration [PESA]

• No planned testicular sperm extraction [TESE]

• No known history or risk of severe hyperstimulation

• No evidence of hydrosalpinx

• No major systemic disease

• No uterine abnormality

• No previous ovarian surgery